Search:
You do not have permission to access this chart.
Please Sign Up or Login
News for Benitec Biopharma Inc. (BNTC)
minutes ago | Banggood.com
58 minutes ago | Aliexpress.com
3 months ago | PRNewsWire
3 months ago | PRNewsWire
4 months ago | Pulse2
4 months ago | Benzinga
4 months ago | InvestorPlace
4 months ago | Benzinga
4 months ago | Pulse2
Benitec Biopharma's Gene Therapy For Rare Muscle Disorder Shows Encouraging Action In Animal Studies
5 months ago | Benzinga
8 months ago | PRNewsWire
About:
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy and chronic hepatitis B virus infection. The company was founded in 1995 and is headquartered in Hayward, California.